Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

BCX4430 - A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease.

Taylor R, Kotian P, Warren T, Panchal R, Bavari S, Julander J, Dobo S, Rose A, El-Kattan Y, Taubenheim B, Babu Y, Sheridan WP.

J Infect Public Health. 2016 May-Jun;9(3):220-6. doi: 10.1016/j.jiph.2016.04.002. Epub 2016 Apr 16. Review.

2.

Population pharmacokinetics of peramivir in healthy volunteers and influenza patients.

Matsuo Y, Ishibashi T, Hollister AS, Wajima T.

Antimicrob Agents Chemother. 2015 Nov;59(11):6755-62. doi: 10.1128/AAC.00799-15. Epub 2015 Aug 17.

3.

BCX4430, a novel nucleoside analog, effectively treats yellow fever in a Hamster model.

Julander JG, Bantia S, Taubenheim BR, Minning DM, Kotian P, Morrey JD, Smee DF, Sheridan WP, Babu YS.

Antimicrob Agents Chemother. 2014 Nov;58(11):6607-14. doi: 10.1128/AAC.03368-14. Epub 2014 Aug 25.

4.

Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.

Hernandez JE, Adiga R, Armstrong R, Bazan J, Bonilla H, Bradley J, Dretler R, Ison MG, Mangino JE, Maroushek S, Shetty AK, Wald A, Ziebold C, Elder J, Hollister AS, Sheridan W; eIND Peramivir Investigators..

Clin Infect Dis. 2011 Mar 15;52(6):695-706. doi: 10.1093/cid/cir001.

5.

Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir.

Bantia S, Parker CD, Ananth SL, Horn LL, Andries K, Chand P, Kotian PL, Dehghani A, El-Kattan Y, Lin T, Hutchison TL, Montgomery JA, Kellog DL, Babu YS.

Antimicrob Agents Chemother. 2001 Apr;45(4):1162-7.

6.

Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140.

Bantia S, Ghate AA, Ananth SL, Babu YS, Air GM, Walsh GM.

Antimicrob Agents Chemother. 1998 Apr;42(4):801-7.

Supplemental Content

Loading ...
Support Center